About CureDuchenne

The global leader in Duchenne research, patient care and innovation, CureDuchenne is committed to finding and funding a cure for Duchenne muscular dystrophy while delivering the education and resources to support patients, families, caregivers and healthcare providers.
Founded by Paul and Debra Miller in 2003, after their son was diagnosed with the disease, CureDuchenne combines fundraising and venture philanthropy leveraging donor dollars to maximize support for promising research into effective treatments for those suffering from Duchenne.
With transparency as a core value, investment proceeds are redeployed to support research and other mission critical programs to find a cure.